The most promising areas of tech disruption in Pharmaceuticals and Healthcare industries are Patient-faced services and new tech for Clinical trials and Healthcare providers.
Healthcare data integration platform Innovaccer announced that it has raised an additional $10 million in funding, boosting its Series B funding round up to $35 million. The company’s product InData is a unified health data integration platform that offer providers see a full view of a patient’s data, both inside and outside of their network.
Ciitizen, a tech startup focused building easy-to-share digital health records, has raised $17 million in Series A funding. The company aims to solve the many problems of healthcare data sharing and lack of interoperability by creating a patient-centered medical record.
TransformativeMed, maker of EHR-friendly clinician coordination and messaging software, has raised $5.8 million in a Series A financing round led by Alliance of Angels. The software incorporates machine learning to surface relevant data as the clinician works within the EHR, supports messaging and texting, and can integrate with smartphones to keep clinicians in the loop in case of critical alerts.
Apple is opening the doors to its mobile Health Records feature even wider by allowing US health care organizations with compatible EHRs to self-register for the personal health record system. Registering a system or clinic allows patients to download their health records to the phone upon providing the credentials to their existing patient portal. Additionally, the provider’s brand or locations will be surfaced within the personal health record feature when searched by a user.
AI Diagnostic Tools
Israel-based deep learning startup Zebra Medical Vision announced that it has received an 510(k) clearance for an artificial intelligence tool that can read medical imaging to identify potential cases of pneumothorax — a build-up of gas between a lung and the chest wall.
The system scans a chest X-ray or digital radiography scan for signs of the condition, and then flags the image for review by the clinical team.
French startup Lifen is raising a $22 million funding round. Lifen acts as an interface with multiple electronic messaging protocols — MS Santé, Apicrypt, Zepra and Medimail. The user can send a letter using those protocols in a few clicks. And because the paper isn’t going to die overnight, users can also send letters through the French postal service using Lifen as well.